Effect of Prior Therapy on the Efficacy and Safety of Oral Selinexor in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): A Post-Hoc Analysis of the Sadal Study

被引：1

作者：

Cavallo, Federica ^{[1
]}

Follows, George A. ^{[2
]}

Goy, Andre ^{[3
]}

Vermaat, Joost ^{[4
]}

Casasnovas, Rene-Olivier ^{[5
]}

Lavee, Orly ^{[6
]}

Maerevoet, Marie ^{[7
]}

Zijlstra, Josee M. ^{[8
]}

Bakhshi, Sameer ^{[9
]}

Bouabdallah, Reda

Choquet, Sylvain ^{[10
,11
]}

Gurion, Ronit ^{[12
]}

Hill, Brian T. ^{[13
]}

Jaeger, Ulrich ^{[14
]}

Sancho, Juan-Manuel ^{[15
]}

Schuster, Michael W. ^{[16
]}

Thieblemont, Catherine ^{[17
,18
]}

De la Cruz, Fatima ^{[19
]}

Egyed, Miklos ^{[20
]}

Mishra, Sourav ^{[21
]}

Offner, Fritz ^{[22
]}

Vassilakopoulos, Theodoros P. ^{[23
]}

Warzocha, Krzysztof ^{[24
]}

McCarthy, Daniel ^{[25
]}

Ma, Xiwen ^{[25
]}

Corona, Kelly ^{[25
]}

Saint-Martin, Jean-Richard ^{[25
]}

Joshi, Anita ^{[25
]}

Shah, Jatin ^{[25
]}

Van den Neste, Eric ^{[26
]}

Canales, Miguel A. ^{[27
]}

Kalakonda, Nagesh ^{[28
]}

机构：

[1] Univ Torino, Div Hematol, AOU Citta Salute & Sci, Turin, Italy

[2] Cambridge Univ Hosp NHS Fdn Trust, UK CLL Forum, Haematol, Cambridge, England

[3] Hackensack Univ Med Ctr, John Theurer Canc Ctr, Hackensack, NJ USA

[4] Leiden Univ Med Ctr, Dept Hematol, Leiden, Netherlands

[5] Univ Dijon, Dept Hematol, CHU Hop Francois Mitterrand, Dijon, France

[6] St Vincents Hosp, Darlinghurst, NSW, Australia

[7] ULB, Inst Jules Bordet, Dpt Hematol, Brussels, Belgium

[8] Vrije Univ Amsterdam, Canc Ctr Amsterdam, Dept Hematol, Amsterdam UMC, Amsterdam, Netherlands

[9] All India Inst Med Sci, Dr BRA Inst Rotary Canc Hosp, New Delhi, India

[10] Inst Paoli Calmettes, Dept Hematol, Marseille, France

[11] Hosp Pitie Salpetriere, Paris, France

[12] Rabin Med Ctr, Inst Hematol, Davidoff Canc Ctr, Petah Tiqwa, Israel

[13] Cleveland Clin, Cleveland, OH 44106 USA

[14] Med Univ Vienna, Vienna, Austria

[15] Hosp Badalona Germans Trias & Pujol, Barcelona, Spain

[16] SUNY Stony Brook, Hosp Canc Ctr, Stony Brook, NY USA

[17] Hop St Louis, AP HP, Hemato Oncol, Paris, France

[18] Diderot Univ, Sorbonne Paris Cite, Paris, France

[19] Hosp Univ Virgen del Rocio, Seville, Spain

[20] Mor Kaposi Teaching Hosp, Kaposvar, Hungary

[21] Inst Med Sci & SUM Hosp, Bhubaneswar, Odisha, India

[22] Univ Ziekenhuis Gent, Ghent, Belgium

[23] Natl & Kapodistrian Univ Athens, Laikon Gen Hosp, Athens, Greece

[24] Inst Haematol & Transfus Med, Clin Haematol, Warsaw, Poland

[25] Karyopharm Therapeut, Newton, MA USA

[26] Clin Univ St Luc, Brussels, Belgium

[27] Hosp Univ La Paz, Madrid, Spain

[28] Univ Liverpool, Liverpool, Merseyside, England

来源：

BLOOD | 2019年 / 134卷

关键词：

D O I：

10.1182/blood-2019-122900

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

5333

引用

页数：6

共 50 条

[41] Radiotherapy Combined Chimeric Antigen Receptor T-Cells Therapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma(R/R DLBCL)
Zhou, Lili
Liu, Yifan
Ye, Shiguang
Li, Ping
Li, Shaoguang
Liang, Aibin
BLOOD, 2023, 142
[42] HEALTH UTILITY IN RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (RR-DLBCL) PATIENTS - RESULTS OF A PHASE II TRIAL WITH ORAL SELINEXOR
Casasnovas, R. O.
Daniele, P.
Tremblay, G.
Maerevoet, M.
Zijlstra, J.
Follows, G.
Vermaat, J. S. P.
Kalakonda, N.
Goy, A. H.
Choquet, S.
Van den Neste, E.
Hill, B. T.
Thieblemont, C.
Cavallo, F.
de la Cruz, F.
Kuruvilla, J.
Hamad, N.
Bouabdallah, R.
Jaeger, U.
Caimi, P.
Gurion, R.
Warzocha, K.
Bakhshi, S.
Sancho, J. M.
Schuster, M.
Egyed, M.
Offner, F.
Vasilakopoulos, T.
Samal, P.
Nagy, A.
Ku, M.
Canales Albendea, M. A.
VALUE IN HEALTH, 2020, 23 : S479 - S480
[43] Modified R-DAOx as salvage therapy in patients with relapsed or refractory diffuse large B-cell lymphoma
Rigacci, L.
Fabbri, A.
Mappa, S.
Nassi, L.
Lenoci, M.
Puccini, B.
Alterini, R.
Chitarrelli, I
Carrai, V
Lauria, F.
Bosi, A.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 61 - 61
[44] Modified R-DHAOx as salvage therapy in patients with relapsed or refractory diffuse large B-cell lymphoma
Fabbri, A.
Rigacci, L.
Lenoci, M.
Mappa, S.
Puccini, B.
Nassi, L.
Chitarrelli, I.
Gozzetti, A.
Alterini, R.
Carrai, V.
Bosi, A.
Lauria, F.
ANNALS OF ONCOLOGY, 2008, 19 : 219 - 220
[45] Tafasitamab for the Treatment of Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) in the US Real-World Setting
Saverno, Kimberly
Savill, Kristin M. Zimmerman
Feinberg, Bruce
Galvin, John
Pathak, Prathamesh
Gordon, Sarah
Amoloja, Theresa
Llorente, Mae
Epperla, Narendranath
Nastoupil, Loretta J.
BLOOD, 2023, 142
[46] Preferences and Perceptions Regarding Treatment Decision-Making for Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
Yung, Mallory
Schnell, Frederick
Vukcevic, Mirko
Kurukulasuriya, Nuwan C.
BLOOD, 2021, 138 : 1928 - +
[47] SINGLE AGENT ORAL SELINEXOR EXHIBITS DURABLE RESPONSES IN RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) OF BOTH GCB AND NON-GCB SUBTYPES: THE PHASE 2B SADAL STUDY
Maerevoet, M.
Westin, J.
Thieblemont, C.
Zijlstra, J.
Hill, B. T.
De La Cruz Vicente, F.
Choquet, S.
Caimi, P.
Kaplan, J.
Canales, M. A.
Kuruvilla, J.
Follows, G.
Van den Neste, E.
Meade, J.
Wrigley, B.
Devlin, M.
Saint-Martin, J. -R.
Nippgen, C.
Gardner, H.
Shacham, S.
Kauffman, M. G.
Casasnovas, R. -O.
HAEMATOLOGICA, 2017, 102 : 173 - 174
[48] Five-Year Efficacy and Safety of Tafasitamab in Patients With Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): Final Results From the Phase II L-MIND Study
Duell, Johannes
Abrisqueta, Pau
Andre, Marc
Augustin, Marinela
Gaidano, Gianluca
Gonzalez Barca, Eva
Jurczak, Wojciech
Kalakonda, Nagesh
Liberati, Anna Marina
Maddocks, Kami J.
Menne, Tobias
Nagy, Zsolt
Tournilhac, Olivier
Bakuli, Abhishek
Amin, Aasim
Gurbanov, Konstantin
Salles, Gilles
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S433 - S434
[49] Phase 1b/3 study of avelumab-based combination regimens in patients with relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL).
Chen, Robert W.
Ansel, Stephen Maxted
Zinzani, Pier Luigi
Vacirca, Jeffrey L.
Lopez-Guillermo, Armando
Hutchings, Martin
Jurczak, Wojciech
Hess, Georg
Le Gouill, Steven
Offner, Fritz
Santoro, Armando
Salles, Gilles A.
Stypinski, Darla
Laird, Douglas
Pavlov, Dmitri
Andreola, Giovanna
Fly, Kolette D.
Woolfson, Adrian
Collins, Graham P.
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[50] Single Agent Oral Selinexor Demonstrates Deep and Durable Responses in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) in Both GCB and Non GCB Subtypes: The Phase 2b Sadal Study
Maerevoet, Marie
Vermaat, Joost
Canales, Miguel A.
Casasnovas, Rene-Olivier
Van den Neste, Eric
Goy, Andre
Hill, Brian T.
Thieblemont, Catherine
De Fatima De La Cruz, Maria
Cavallo, Federica
Follows, George
Choquet, Sylvain
Gurion, Ronit
Bouabdallah, Reda
Jaeger, Ulrich
Nagy, Agnes
Kuruvilla, John
Warzocha, Krzysztof
Kalakonda, Nagesh
Caimi, Paolo
Bakhshi, Sameer
Ku, Matthew
Hamad, Nada
Veelken, Hendrik
Matczak, Ewa
Ma, Xiwen
Saint-Martin, Jean-Richard
Shah, Jatin J.
Kauffman, Michael G.
Shacham, Sharon
Zijlstra, Josee M.
BLOOD, 2018, 132

← 1 2 3 4 5 →